GENB
Generate Biomedicines, Inc. Common StockNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$1.51B
P/E Ratio
—
EPS
$-2.18
Beta
—
52W High
$16.00
52W Low
$11.00
50-Day MA
$12.31
200-Day MA
$12.31
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Generate Biomedicines, Inc. Common Stock
None
Fundamentals
| Revenue (TTM) | $31.89M |
| Gross Profit (TTM) | $-192.80M |
| EBITDA | $-221.89M |
| Operating Margin | -737.00% |
| Return on Equity | -81.70% |
| Return on Assets | -34.60% |
| Revenue/Share (TTM) | $0.64 |
| Book Value | $-12.24 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | 47.27 |
| EV/Revenue | 49.93 |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $127.45M |
| Float | $48.25M |
| % Insiders | 22.62% |
| % Institutions | 0.00% |
Analyst Ratings
Consensus ($25.00 target)
2
Strong Buy3
BuyData last updated: 4/8/2026